Spondylodiscitis after facet joint steroid injection: a case report and review of the literature.
Spondylodiscitis is a rare complication after facet joint steroid injection. This article presents a 78-y-old male with chronic back pain and facet joint arthritis who developed Pseudomonas aeruginosa L2-L3 and L3-L4 spondylodiscitis after computed tomography-guided facet joint steroid injection. Magnetic resonance imaging, fine needle aspiration and cultures confirmed the diagnosis. The patient was treated with intravenous administration of amikacin, and imipenem plus cilastatin for 4 weeks, followed by oral administration of ciprofloxacin for another 10 weeks. Sterile preparation prior to facet joint steroid injection should be stressed. To the best of our knowledge, this is the only reported case of iatrogenic spondylodiscitis after facet joint steroid injection. This iatrogenic complication should be considered in the risk-benefit analysis of facet joint diagnostic or therapeutic injections.
Falagas
Matthew E
ME
Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece. matthew.falagas@tufts.edu
Bliziotis
Ioannis A
IA
Mavrogenis
Andreas F
AF
Papagelopoulos
Panayiotis J
PJ
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D015299:Discitis / Q000000981:diagnostic imaging / Q000209:etiology*; D006801:Humans; D007278:Injections, Spinal / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008297:Male; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011859:Radiography; D021801:Zygapophyseal Joint
D000900:Anti-Bacterial Agents